+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Recent advances in magnetofection and its potential to deliver siRNAs in vitro



Recent advances in magnetofection and its potential to deliver siRNAs in vitro



Methods in Molecular Biology 487: 111-146



This chapter describes how to design and conduct experiments to deliver siRNA to adherent mammalian cells in vitro by magnetic force-assisted transfection using self-assembled complexes of small interfering RNA (siRNA) and cationic lipids or polymers that are associated with magnetic nanoparticles. These magnetic complexes are targeted to the cell surface by the application of a magnetic gradient field. In this chapter, first we describe the synthesis of magnetic nanoparticles for magnetofection and the association of siRNA with the magnetic components of the transfection complex. Second, a simple protocol is described in order to evaluate magnetic responsiveness of the magnetic siRNA transfection complexes and estimate the complex loading with magnetic nanoparticles. Third, protocols are provided for the preparation of magnetic lipoplexes and polyplexes of siRNA, magnetofection, downregulation of gene expression, and the determination of cell viability. The addition of INF-7 peptide, a fusogenic peptide, to the magnetic transfection triplexes improved gene silencing in HeLa cells. The described protocols are also valuable for screening vector compositions and novel magnetic nanoparticle preparations to optimize siRNA transfection by magnetofection in every cell type.

(PDF emailed within 0-6 h: $19.90)

Accession: 055398051

Download citation: RISBibTeXText

PMID: 19301645

DOI: 10.1007/978-1-60327-547-7_6


Related references

Recent advances in plant-virus interaction with emphasis on small interfering RNAs (siRNAs). Molecular Biotechnology 55(1): 63-77, 2014

siRNAs: their potential as therapeutic agents--Part I. Designing of siRNAs. Drug Discovery Today 14(17-18): 851-858, 2009

In Silico, In Vitro, and In Vivo Studies Indicate the Potential Use of Bolaamphiphiles for Therapeutic siRNAs Delivery. Molecular Therapy — Nucleic Acids 2(3), 2013

Strontium Sulfite: A New pH-Responsive Inorganic Nanocarrier to Deliver Therapeutic siRNAs to Cancer Cells. Pharmaceutics 11(2), 2019

Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells. Nucleic Acids Research 41(7): 4266-4283, 2013

In vitro and in vivo Magnetofection : a move towards gene therapy. Annales de Biologie Clinique 68(2): 133-142, 2010

Recent advances in ERG. (II). Early potential. Ganka. Ophthalmology 9(6): 414-425, 1967

In situ preparation of magnetic nonviral gene vectors and magnetofection in vitro. Nanotechnology 21(11): 115103, 2010

Recent advances and the potential for clinical use of xenotransplantation. Current Opinion in Cardiology 11(2): 214-220, 1996

Recent and potential advances in DSDP biostratigraphy. AAPG Bulletin 63(3): 516, 1979

Recent advances in the use of rice genetic potential. Comptes Rendus de l'Academie d'Agriculture de France 82(7): 79-90, 1996

Recent and potential advances in cancer chemotherapy. Advances in Pathobiology 4: 118-132, 1976

Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Therapy 9(2): 102-109, 2002

Magnetofection--a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Molecular Therapy 7(5 Pt 1): 700-710, 2003

Recent advances in the use of in vitro techniques. Alternatives to laboratory animals: ATLA 15(2): 152-154, 1987